Sort
10,766 grants matching “checkpoint inhibitor”
Immunological changes associated with antibiotic use in oropharyngeal cancer
$292,523Stephanie Dorta-Estremera · University Of Puerto Rico Med Sciences · P20 · FY2025 · GM
CD44 Promotes Chronic Virus Infection
$292,500Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2018 · AI
Regulation of CD4+ T cell responses during chronic viral infection
$292,500Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2020 · AI
Checkpoint abrogation and MEK1/2 inhibition in myeloma
$292,275Virginia Commonwealth University · R01 · FY2003 · CA
TUMOR AND IMMUNO-METABOLISM BASED LACTATE TRANSPORTER INHIBITORs FOR METASTATIC MELANOMA
$292,210Vincent Sandanayaka · Nirogyone Therapeutics, Llc · R43 · FY2019 · CA
Targeted Therapy for Endometrial Cancer
$291,967Kimberly K Leslie · University Of Iowa · R01 · FY2019 · CA
HIV 1 VPR INDUCES G2 CELL CYCLE ARREST AND APOPTOSIS
$291,650University Of California Los Angeles · R01 · FY2001 · CA
Therapeutic targeting of stratifin structure and function
$291,366Jian-Ting Zhang · Indiana University Indianapolis · R01 · FY2013 · CA
S Checkpoint Function in Human Fibroblasts
$291,000University Of North Carolina Chapel Hill · R01 · FY2002 · ES
S Checkpoint Function in Human Fibroblasts
$291,000University Of North Carolina Chapel Hill · R01 · FY2003 · ES
S Checkpoint Function in Human Fibroblasts
$291,000University Of North Carolina Chapel Hill · R01 · FY2004 · ES
TR&D Project 3
$290,858Jamie Berta Spangler · Johns Hopkins University · P41 · FY2025 · EB
Alaska INBRE 4 One Health
$290,737Brian M Barnes · University Of Alaska Fairbanks · P20 · FY2020 · GM
Project 4: Combined use of immunotherapy and targeted treatments for triple negative breast cancer
$290,647Kornelia Polyak · Dana-Farber Cancer Inst · P50 · FY2022 · CA
Project 3 Gene Mediated Cytotoxic Immmunotherapy for GBM
$290,642E. Antonio Chiocca · Massachusetts General Hospital · P01 · FY2021 · CA
Project 3 Gene Mediated Cytotoxic Immmunotherapy for GBM
$290,642E. Antonio Chiocca · Massachusetts General Hospital · P01 · FY2020 · CA
Intestinal Cell Growth Control: Role of Tyrosine Kinases
$290,357Christine Ann Cartwright · Stanford University · R01 · FY2007 · DK
RAPAMYCIN INDUCED SELECTIVE APOPTOSIS IN MALIGNANT CELLS
$290,291St. Jude Children'S Research Hospital · R01 · FY2000 · CA
Genetic contributions to T cell mediated immunopathology after viral infection
$290,250Brian Martin Sullivan · Scripps Research Institute, The · R21 · FY2019 · AI
MECHANISMS OF RADIORESISTANCE AND CELL CYCLE PROGRESSION
$290,198Columbia University Health Sciences · R01 · FY2000 · GM
Novel recombinant BCG for immunotherapy of bladder cancer
$290,014Boris Shor · Manhattan Biosolutions, Llc · R43 · FY2018 · CA
Project 2
$289,930Felicity Harper · Wayne State University · P20 · FY2023 · CA
The Impact of PD-1 Inhibition on Immune-Response to Chemoradiotherapy
$289,754Steven Francis Powell · Sanford Research/Usd · P20 · FY2018 · GM
Project 2
$289,614Tomas Kirchhoff · New York University School Of Medicine · P50 · FY2020 · CA
Mechanisms of Sensitivity to Cell Cycle Checkpoint Kinase Inhibitors
$289,609Alan R Eastman · Dartmouth College · R01 · FY2014 · CA